Navigation Links
BMP Sunstone Compliance Receives Nasdaq Notice
Date:5/1/2009

PLYMOUTH MEETING, Pa., May 1 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP; "BMP Sunstone" or the "Company") today announced that on April 29, 2009, it received a letter from the staff of The Nasdaq Stock Market LLC indicating that the Company had violated the shareholder approval rules under Listing Rule 5635(d)(2) in connection with the Company's sale of 574,687 units, each consisting of two shares of the Company's common stock and one warrant, on February 13, 2009; $7,000,000 of 12.5% subordinated convertible notes on March 13, 2009; and $6,350,000 of 12.5% secured convertible notes on March 16, 2009.

The Company regained compliance after amending the terms of the 12.5% subordinated convertible notes, and its related indenture, so that the subordinated convertible notes may not be converted into the Company's common stock in violation of Listing Rule 5635(d)(2). As a result, the staff of The Nasdaq Stock Market LLC determined that the Company has regained compliance and that, with this press release, the matter is now closed.

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 120,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit www.bmpsunstone.com.


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BMP Sunstone Appoints Les R. Baledge to Board of Directors
2. BMP Sunstone Exchanges and Calls Outstanding Notes Due May 2009
3. BMP Sunstone Reiterates Commitment to Quality, Innovation and Long-Term Growth at Meeting with Senior Officials
4. BMP Sunstone Announces Exchange Offer of $10.7 Million of Outstanding Secured Notes
5. BMP Sunstone to Report Third Quarter 2008 Financial Results
6. BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co.
7. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
8. BMP Sunstone Announces Official Launch of Ferriprox in PRC
9. BMP Sunstone Announces Participation in June Investor Conferences
10. BMP Sunstone Reports First Quarter 2008 Financial Results
11. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: